P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY

Detalles Bibliográficos
Autores principales: Lansigan, Frederick, A. Eyre, Toby, Ghosh, Nilanjan, S. Manzoor, Beenish, C. Coombs, Catherine, Lamanna, Nicole, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, E. Roeker, Lindsey, Ujjani, Chaitra, Alhasani, Hasan, Fleury, Isabelle, A. Leslie, Lori, Skarbnik, Alan, Rhodes, Joanna, T. Hill, Brian, M. Barr, Paul, S. Davids, Matthew, P. Fox, Christopher, Choi, Yun, Schuh, Anna, Kennard, Kaitlin, E. Jensen, Christopher, Jawaid, Dureshahwar, Sharma, Aditya, Pivneva, Irina, Watson, Talissa, Shadman, Mazyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428921/
http://dx.doi.org/10.1097/01.HS9.0000969496.68553.26

Ejemplares similares

Ejemplares similares